Eidos Therapeutics, Inc.

TUDOR INVESTMENT CORP ET AL
Report date
12/31/2020
Quarter
2020 Q4
Filed
2/16/2021
Shares
155,671
Value ($000)
20,483
Weight
0.6%
2020 Q4 - 2020 Q4 (1 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).